Ju J - Search Results

1

microRNA based prognostic biomarkers in pancreatic Cancer.

Guo S, Fesler A, Wang H, Ju J. Guo S, et al. Among authors: ju j. Biomark Res. 2018 May 21;6:18. doi: 10.1186/s40364-018-0131-1. eCollection 2018. Biomark Res. 2018. PMID: 29942514 Free PMC article. Review.

2

MicroRNA: a third dimension in autophagy.

Zhai H, Fesler A, Ju J. Zhai H, et al. Among authors: ju j. Cell Cycle. 2013 Jan 15;12(2):246-50. doi: 10.4161/cc.23273. Epub 2012 Jan 15. Cell Cycle. 2013. PMID: 23255136 Free PMC article. Review.

3

miRNA: the new frontier in cancer medicine.

Ju J, Jiang J, Fesler A. Ju J, et al. Future Med Chem. 2013 Jun;5(9):983-5. doi: 10.4155/fmc.13.74. Future Med Chem. 2013. PMID: 23734680 Free PMC article. No abstract available.

4

Clinical significance of long intergenic noncoding RNA-p21 in colorectal cancer.

Zhai H, Fesler A, Schee K, Fodstad O, Flatmark K, Ju J. Zhai H, et al. Among authors: ju j. Clin Colorectal Cancer. 2013 Dec;12(4):261-6. doi: 10.1016/j.clcc.2013.06.003. Epub 2013 Sep 5. Clin Colorectal Cancer. 2013. PMID: 24012455

5

Prognostic significance of miR-194 in endometrial cancer.

Zhai H, Karaayvaz M, Dong P, Sakuragi N, Ju J. Zhai H, et al. Among authors: ju j. Biomark Res. 2013;1:12. doi: 10.1186/2050-7771-1-12. Biomark Res. 2013. PMID: 24040515 Free PMC article.

6

miR-15a inhibits cell proliferation and epithelial to mesenchymal transition in pancreatic ductal adenocarcinoma by down-regulating Bmi-1 expression.

Guo S, Xu X, Tang Y, Zhang C, Li J, Ouyang Y, Ju J, Bie P, Wang H. Guo S, et al. Among authors: ju j. Cancer Lett. 2014 Mar 1;344(1):40-46. doi: 10.1016/j.canlet.2013.10.009. Epub 2013 Nov 16. Cancer Lett. 2014. PMID: 24252251

7

Circulating microRNA testing for the early diagnosis and follow-up of colorectal cancer patients.

Fesler A, Jiang J, Zhai H, Ju J. Fesler A, et al. Among authors: ju j. Mol Diagn Ther. 2014 Jun;18(3):303-8. doi: 10.1007/s40291-014-0089-0. Mol Diagn Ther. 2014. PMID: 24566942 Free PMC article. Review.

8

miR-129 as a novel therapeutic target and biomarker in gastrointestinal cancer.

Fesler A, Zhai H, Ju J. Fesler A, et al. Among authors: ju j. Onco Targets Ther. 2014 Aug 21;7:1481-5. doi: 10.2147/OTT.S65548. eCollection 2014. Onco Targets Ther. 2014. PMID: 25187728 Free PMC article. Review.

9

Inhibition of colorectal cancer stem cell survival and invasive potential by hsa-miR-140-5p mediated suppression of Smad2 and autophagy.

Zhai H, Fesler A, Ba Y, Wu S, Ju J. Zhai H, et al. Among authors: ju j. Oncotarget. 2015 Aug 14;6(23):19735-46. doi: 10.18632/oncotarget.3771. Oncotarget. 2015. PMID: 25980495 Free PMC article.

10

Identification of miR-215 mediated targets/pathways via translational immunoprecipitation expression analysis (TrIP-chip).

Fesler A, Xu X, Zheng X, Li X, Jiang J, Russo JJ, Ju J. Fesler A, et al. Among authors: ju j. Oncotarget. 2015 Sep 15;6(27):24463-73. doi: 10.18632/oncotarget.4425. Oncotarget. 2015. PMID: 26287603 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,535 results

Search Page

Filters